Shares of biotech company 10x Genomics (NASDAQ:TXG) jumped 4.8% in the morning session after Canaccord Genuity maintained its 'Buy' rating and raised its price target on the company's shares. The firm ...

10X Health's patented system translates your genetics into customized nutrition plans, supplements, and IV treatments available globally through REVIV clinics in 40+ countries. In an age where social ...

We recently compiled a list of the 7 Most Promising Gene Editing Stocks According to Analysts. 10x Genomics, Inc. is one of the seven stocks on our list of most promising stocks. On December 15, 2025, ...

10x Banking, the cloud-native core banking platform, has partnered with audax Financial Technology, a digital banking technology solutions provider supported by Standard Chartered, to transform how ...

The initial public offering (IPO) market is expected to see exceptional strength in 2026, with high-profile firms like SpaceX (SPACE) and OpenAI (OPENAI) among the likely contenders to go public.

Bitcoin (CRYPTO: BTC) is not resting within a bull market, but is firmly in a bear market, according to 10x Research head Marcus Thielen. What Happened: Speaking on a recent Coin Bureau podcast with ...

The Metals Company controls 51 million metric tons of battery metal reserves on the ocean floor worth potentially $600B or more. The company targets commercial production by late 2027 but may receive ...

Farran Powell is the managing editor of investing at Forbes Advisor. She was previously the assistant managing editor of investing at U.S. News & World Report. Her work has appeared in numerous ...

A published image of a 10X prototype in Bordeaux appears to show ground tests underway According to sources, the Dassault Falcon 10X is expected to begin flight testing in 2026.

10X Genomics, Inc. is a life science technology company, which engages in building products to interrogate, understand and master biology. Its integrated solutions include single cell transcriptomics, ...